Nymox Pharmaceutical Corp (NYMX)

NASDAQ
0.3050
-0.0026(-0.85%)
Pre Market
0.3000
-0.0050(-1.64%)
- Real-time Data
  • Volume:
    26,084
  • Day's Range:
    0.3012 - 0.3087
  • 52 wk Range:
    0.1850 - 2.1000

NYMX Overview

Prev. Close
0.3076
Day's Range
0.3012-0.3087
Revenue
-
Open
0.3012
52 wk Range
0.185-2.1
EPS
-0.091
Volume
26,084
Market Cap
27.84M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
72,605
P/E Ratio
-3.56
Beta
0.73
1-Year Change
-78.52%
Shares Outstanding
91,265,000
Next Earnings Date
-
What is your sentiment on Nymox Pharmaceutical?
or
Market is currently closed. Voting is open during market hours.

Nymox Pharmaceutical Corp News

Nymox Pharmaceutical Corp Analysis

Nymox Pharmaceutical Corp Company Profile

Nymox Pharmaceutical Corp Company Profile

Employees
0

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease, as well as researches and develops drug treatments for Alzheimer’s disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell